Vaccines

New technologies offer cheaper modes of manufacture – here’s how and why the world’s less wealthy countries could seize the moment.

Anti-vaccine activists are suing a number of prominent media outlets, including Reuters, the Washington Post, the BBC, and the Associated Press.

The International Vaccine Institute is working to make a difference for vaccine manufacture in the world’s less wealthy regions

From hemispheric analysis to hatchery logistics, there’s a lot more to vaccine production than you might suspect

Though key hurdles remain, there is huge potential for mRNA-based therapeutics to tackle areas of unmet need.

Could dry vaccines help improve global access to the latest vaccine technologies?

Exploring the potential of self-amplifying RNA and circular RNA in the future of drug development.

How two rival projects relate to a modern disease landscape threatened by climate change and low vaccination rates

Experts from Sartorius give advice on the next generation processes and facilities for mRNA manufacture.

How can our knowledge of mRNA vaccine development influence our Industry 4.0 journeys?